ClinicalTrials.Veeva

Menu

Effects of Virtual Reality Training for Stroke Patients

S

Sultan Qaboos University

Status

Unknown

Conditions

Stroke Patients

Treatments

Device: Virtual Reality (VR)

Study type

Interventional

Funder types

Other

Identifiers

NCT05178758
MREC #2593

Details and patient eligibility

About

To examine the effects of using a virtual reality (VR) system to improve upper limb motor function among subacute hemiparetic stroke patients. Under this aim, the investigators have two objectives: (1) to develop and test a procedure for the quantitative assessment of stroke patients in a virtual environment; and (2) to compare the outcome measures of the two groups of stroke patients (VR-intervention vs. conventional-control) on these two modes of training.

Full description

After being informed about the study and potential risks, all participants who gave written consent will undergo the study. A randomized controlled trial with pre-/post-study, of 42 stroke patients with upper limb weakness (21 patients in the control group and 21 patients in the intervention group), 18-65 years old, all are newly admitted stroke patients in the rehabilitation clinic from one hospital. Participants in the intervention group will receive 60 minutes of VR training to improve upper limb function and daily living activities. Participants in the control group will receive 60 minutes of conventional training to improve upper limb function and daily living activities. The training includes grasp, grip, pinch, gross, and finger-hand coordination movement. The training will perform 5 times/week for 4 weeks. Two outcome measures: (a) The Barthel Index and (b) The Fugl-Meyer Assessment, time spent to complete a task were used to compare two groups.

Enrollment

42 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. New in-patients clinically diagnosed hemiparetic stroke patients;
  2. Patients with a history of the first incidence of stroke with upper limb weakness with a motor impairment upper limbs as a primary deficit;
  3. muscle strength > 2/5 on the Medical Research Council (MRC) scale;
  4. good cognitive ability as indicated by a score > 15 on the Mini-Mental State Examination (MMSE); Motricity Index sore > 26; and
  5. ability to communicate and sign the consent.

Exclusion criteria

  1. In-patient with ataxia or any other cerebellar symptoms;
  2. orthopedic alterations or pain syndrome of the upper limb;
  3. peripheral nerve damage affecting the upper extremities;
  4. visual or hearing impairment (does not allow the possibility of interaction with the VR system);
  5. severe hemispatial neglect;
  6. severe shoulder or hand pain (unable to volitionally position the hand in the workspace without pain);
  7. insensate forearm and /or hand, edema of the affected forearm and /or hand;
  8. uncontrolled seizures disorder;
  9. severe depression (>13 on beck Depression inventory fast screen); and
  10. severely impaired cognition or comprehension.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

42 participants in 2 patient groups

Virtual Reality (VR) Rehabilitation Training
Experimental group
Description:
Patients in the VR group will receive VR rehabilitation training in the hospital. The content of the training is the same as the control group. The only difference is that participants in the intervention group will use VR as a training platform. The VR system will include the training materials and tasks required for the patients to perform in the 3D environment. Demographic, clinical data and treatment costs will be collected before and after the rehabilitation training.
Treatment:
Device: Virtual Reality (VR)
Control - Conventional Rehabilitation Training
No Intervention group
Description:
Patients in the control group will receive conventional rehabilitation training currently provided in the hospital. An instructor will assign each participant for training. Demographic, clinical data, and treatment costs will be collected before and after completing the rehabilitation training

Trial contacts and locations

0

Loading...

Central trial contact

Hamdan Al Habsi; Moon Fai Chan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems